Unlike the forked repo, this one can be built from source on Linux.

Project structure is changed to make Intellij IDE work. gradlew needs to be run from the root directory rather than packages.

krdb 3.3.4/5 <==> Kotlin 2.4.0

krdb 3.3.3 <==> Kotlin 2.3.20

krdb 3.3.2 <==> Kotlin 2.3.10

krdb 3.3.0/1 <==> Kotlin 2.3.0

krdb 3.2.9/10 <==> Kotlin 2.2.20

krdb 3.2.8 <==> Kotlin 2.2.0

krdb 3.2.6/7 <==> Kotlin 2.1.20

krdb 3.2.5 <==> Kotlin 2.1.10

• in project build.gradle, add:

buildscript {
    dependencies {
        classpath "io.github.xilinjia.krdb:gradle-plugin:y.y.y"
    }
}

and remove:

id 'io.realm.kotlin' version 'x.x.x' apply false

• in the app build.gradle

in the plugins block, replace: id 'io.realm.kotlin' with id 'io.github.xilinjia.krdb'

replace: implementation "io.realm.kotlin:library-base:x.x.x" with: implementation "io.github.xilinjia.krdb:library-base:y.y.y"

and replace: apply plugin: "io.realm.kotlin" with apply plugin: "io.github.xilinjia.krdb"

• in all kotlin files, replace "io.realm.kotlin" with "io.github.xilinjia.krdb"
• and of course, change your Kotlin to 2.x.y (refer to Version compatibility)

In addition to the above,

• clone this project with: git clone --recursive https://github.com/XilinJia/krdb.git
• build in the project root directory with:

./gradlew clean
./gradlew jvmTest
./gradlew publishToMavenLocal 

• in Android project, in settings.gradle at the project level, add in the beginning:

pluginManagement {
    repositories {
        mavenLocal() // 👈 Add this line
        google()
        mavenCentral()
    }
}

• in project build.gradle, add:

buildscript {
    repositories {
        mavenLocal()
    }
    dependencies {
        classpath "io.github.xilinjia.krdb:gradle-plugin:y.y.y"
    }
}
allprojects {
    repositories {
        mavenLocal()
    }
}

---

Original Readme of Realm-Kotlin can be referenced here

See CONTRIBUTING.md for more details!

Realm Kotlin is published under the Apache 2.0 license.

This product is not being made available to any person located in Cuba, Iran, North Korea, Sudan, Syria or the Crimea region, or to any other person that is not eligible to receive the product under U.S. law.